Loading clinical trials...
Loading clinical trials...
The objective of this study is to assess the long-term safety of Olumacostat Glasaretil gel, 5.0% in patients with acne vulgaris
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Dermira, Inc.
NCT07205107 · Acne Vulgaris
NCT06225570 · Acne Vulgaris
NCT05891795 · Acne Vulgaris
NCT06447480 · Acne Vulgaris
NCT06141330 · Acne Vulgaris
Avant Research Associates, LLC
Guntersville, Alabama
Advanced Research Associates
Glendale, Arizona
Alliance Dermatology & MOHS Center
Phoenix, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions